171 related articles for article (PubMed ID: 8253961)
1. Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.
Kum WW; Laupland KB; See RH; Chow AW
J Clin Microbiol; 1993 Oct; 31(10):2654-60. PubMed ID: 8253961
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.
See RH; Kum WW; Chang AH; Goh SH; Chow AW
Infect Immun; 1992 Jul; 60(7):2612-8. PubMed ID: 1612731
[TBL] [Abstract][Full Text] [Related]
3. Purification and purity assessment of toxic shock syndrome toxin 1.
Rosten PM; Bartlett KH; Chow AW
Rev Infect Dis; 1989; 11 Suppl 1():S110-5; discussion S115-6. PubMed ID: 2494689
[TBL] [Abstract][Full Text] [Related]
4. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
[TBL] [Abstract][Full Text] [Related]
5. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
Reeves MW; Arko RJ; Chandler FW; Bridges NB
Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
7. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing.
Blomster-Hautamaa DA; Kreiswirth BN; Novick RP; Schlievert PM
Biochemistry; 1986 Jan; 25(1):54-9. PubMed ID: 3954993
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.
See RH; Chow AW
Infect Immun; 1992 Aug; 60(8):3456-9. PubMed ID: 1639516
[TBL] [Abstract][Full Text] [Related]
9. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.
Parsonnet J; Gillis ZA
J Infect Dis; 1988 Nov; 158(5):1026-33. PubMed ID: 3263447
[TBL] [Abstract][Full Text] [Related]
10. Role of the adhesion molecule lymphocyte function associated antigen 1 in toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human monocytes.
See RH; Chow AW
Infect Immun; 1992 Nov; 60(11):4957-60. PubMed ID: 1399006
[TBL] [Abstract][Full Text] [Related]
11. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
Parsonnet J; Hickman RK; Eardley DD; Pier GB
J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
[TBL] [Abstract][Full Text] [Related]
12. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
13. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
Hackett SP; Stevens DL
J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.
Jupin C; Anderson S; Damais C; Alouf JE; Parant M
J Exp Med; 1988 Mar; 167(3):752-61. PubMed ID: 3127526
[TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
[TBL] [Abstract][Full Text] [Related]
16. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
17. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
[TBL] [Abstract][Full Text] [Related]
18. Pyrogenic toxins of Staphylococcus aureus in sudden unexpected nocturnal deaths in adults and older children: factors influencing the control of inflammatory responses to toxic shock syndrome toxins.
Al Madani O; Gordon AE; Weir DM; Raza MW; Busuttil A; Blackwell C
FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):207-19. PubMed ID: 10443510
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
20. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
